Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BIVIR influenza treatment trial
2008-004026-16Phase 4Active
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Influenza A infection comparing Tamiflu + Relenza, Tamiflu + placebo and Relenza + placebo (3 arms). Primary endpoint: Primary efficacy endpoint. Started Jul 2008; status: active.
02
Drugs
oseltamivirzanamivir
03
Conditions
Influenza A infection
Beyond the preview
Go deeper on 2008-004026-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004026-16.